# An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of Dapagliflozin

> **NCT02433678** · PHASE4 · COMPLETED · sponsor: **University at Buffalo** · enrollment: 52 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** dapagliflozin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02433678
- **Lead sponsor:** University at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2018-03
- **Final completion:** 2018-11
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2019-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02433678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02433678, "An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of Dapagliflozin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02433678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*